Background Image
Previous Page  9 / 10 Next Page
Information
Show Menu
Previous Page 9 / 10 Next Page
Page Background www.thermofisher.com/bioLC

Sample Preparation

SOLAµ SPE Plates

for

increased sensitivity

Sample Handling

Virtuoso Vials

The highest level of sample

integrity and sample

information possible

Column

MAbPac HIC-Butyl Columns

UHPLC

Vanquish UHPLC Systems

Built for every

biopharma workflow

Mass Spectrometry

Thermo Scientific

Orbitrap Fusion Lumos Tribrid Mass Spectrometers

The new standard in

characterization and quantitation

Antibody Drug Conjugates (ADCs) are a new

and exciting class of drugs designed for

the targeted treatment of certain cancers.

They consist of a monoclonal antibody with

a synthetic small molecule drug or drugs

joined (conjugated) to them. Combining

the capabilities of the monoclonal antibody

with a cancer-killing drug allows sensitive

discrimination between healthy and

diseased cells. Development of these

biotherapeutics is even harder than with

monoclonal antibodies due to the potency

of the attached drug, sometimes called the

“payload” or “warhead”. In addition to the

analysis carried out on standard antibodies,

further characterization is needed to

determine how much of the drug is attached

to the antibody. This is known as Drug to

Antibody Ratio (DAR).

Antibody Drug Conjugates

Recommended Column

Thermo Scientific

MAbPac HIC-Butyl 5µm, 4

.6

×

100 mm column

Product code: 088558

• Antibody drug conjugates (ADC) require

extended characterization to determine the

amount of drug attached to monoclonal

antibody due to potency of attached drug

• Confirmation of Drug to Antibody Ratio (DAR)

for ADC

• Stable at wide pH range 2-12